U.S. Markets open in 2 hrs 7 mins
  • S&P Futures

    3,633.00
    +0.25 (+0.01%)
     
  • Dow Futures

    29,957.00
    -41.00 (-0.14%)
     
  • Nasdaq Futures

    12,116.00
    +40.00 (+0.33%)
     
  • Russell 2000 Futures

    1,848.10
    -3.40 (-0.18%)
     
  • Crude Oil

    45.06
    +0.15 (+0.33%)
     
  • Gold

    1,810.40
    +5.80 (+0.32%)
     
  • Silver

    23.40
    +0.10 (+0.41%)
     
  • EUR/USD

    1.1892
    -0.0004 (-0.0357%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    22.06
    -0.60 (-2.65%)
     
  • GBP/USD

    1.3333
    -0.0026 (-0.1933%)
     
  • USD/JPY

    104.4720
    -0.0080 (-0.0077%)
     
  • BTC-USD

    19,190.90
    -75.74 (-0.39%)
     
  • CMC Crypto 200

    380.79
    +11.04 (+2.98%)
     
  • FTSE 100

    6,397.95
    -34.22 (-0.53%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

AtriCure: 3Q Earnings Snapshot

·1 min read

MASON, Ohio (AP) _ AtriCure Inc. (ATRC) on Thursday reported a loss of $4.9 million in its third quarter.

On a per-share basis, the Mason, Ohio-based company said it had a loss of 11 cents.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.

The medical device maker posted revenue of $54.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $48.2 million.

For the current quarter ending in December, AtriCure said it expects revenue in the range of $56 million to $60 million.

The company expects full-year revenue in the range of $205 million to $209 million.

AtriCure shares have climbed 14% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $37.12, a climb of 28% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRC at https://www.zacks.com/ap/ATRC